These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11094033)

  • 1. Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women.
    Vehkavaara S; Hakala-Ala-Pietilä T; Virkamäki A; Bergholm R; Ehnholm C; Hovatta O; Taskinen MR; Yki-Järvinen H
    Circulation; 2000 Nov; 102(22):2687-93. PubMed ID: 11094033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of transdermal and oral estrogen supplementation on endothelial function, inflammation and cellular redox state.
    Kawano H; Yasue H; Hirai N; Yoshida T; Fukushima H; Miyamoto S; Kojima S; Hokamaki J; Nakamura H; Yodoi J; Ogawa H
    Int J Clin Pharmacol Ther; 2003 Aug; 41(8):346-53. PubMed ID: 12940591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of oral and transdermal estradiol treatment on circulating estradiol fatty acid ester concentrations in postmenopausal women.
    Vihma V; Vehkavaara S; Yki-Järvinen H; Hohtari H; Tikkanen MJ
    J Clin Endocrinol Metab; 2003 Feb; 88(2):588-93. PubMed ID: 12574185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.
    Perera M; Sattar N; Petrie JR; Hillier C; Small M; Connell JM; Lowe GD; Lumsden MA
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1140-3. PubMed ID: 11238498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women.
    Gerhard M; Walsh BW; Tawakol A; Haley EA; Creager SJ; Seely EW; Ganz P; Creager MA
    Circulation; 1998 Sep; 98(12):1158-63. PubMed ID: 9743505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
    Whitcroft SI; Crook D; Marsh MS; Ellerington MC; Whitehead MI; Stevenson JC
    Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different hepatobiliary effects of oral and transdermal estradiol in postmenopausal women.
    Van Erpecum KJ; Van Berge Henegouwen GP; Verschoor L; Stoelwinder B; Willekens FL
    Gastroenterology; 1991 Feb; 100(2):482-8. PubMed ID: 1898652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women.
    Rabbani LE; Seminario NA; Sciacca RR; Chen HJ; Giardina EG
    J Am Coll Cardiol; 2002 Dec; 40(11):1991-9. PubMed ID: 12475460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitution of transdermal estradiol during oral estrogen-progestin therapy in postmenopausal women: effects on hypertriglyceridemia.
    Sanada M; Tsuda M; Kodama I; Sakashita T; Nakagawa H; Ohama K
    Menopause; 2004; 11(3):331-6. PubMed ID: 15167313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low testosterone levels are associated with endothelial dysfunction in oophorectomized early postmenopausal women.
    Rech CM; Clapauch R; de Souza Md; Bouskela E
    Eur J Endocrinol; 2016 Mar; 174(3):297-306. PubMed ID: 26773076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J
    Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women.
    Adami S; Rossini M; Zamberlan N; Bertoldo F; Dorizzi R; Lo Cascio V
    Maturitas; 1993 Nov; 17(3):191-6. PubMed ID: 8133793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study.
    Hemelaar M; van der Mooren MJ; Mijatovic V; Bouman AA; Schijf CP; Kroeks MV; Franke HR; Kenemans P
    Menopause; 2003; 10(6):550-8. PubMed ID: 14627865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of estrogen replacement therapy on insulin sensitivity of glucose metabolism and preresistance and resistance vessel function in healthy postmenopausal women.
    Vehkavaara S; Westerbacka J; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Yki-Järvinen H
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4663-70. PubMed ID: 11134125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women.
    Gilligan DM; Badar DM; Panza JA; Quyyumi AA; Cannon RO
    Am J Cardiol; 1995 Feb; 75(4):264-8. PubMed ID: 7832136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
    Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.